PGY1 Pharmacy Residency Program at TriHealth Good Samaritan Hospital
Residents
Current Pharmacy Resident(s)
Philap Pham, PharmDCollege of Pharmacy: University of Cincinnati Personal Statement: I grew up in North Ridgeville, Ohio, and attended the University of Cincinnati for pharmacy school. During residency, I hope to continue growing as a clinician while exploring my interests in infectious diseases, cardiology, ambulatory care, and critical care. I am still exploring what I would like to pursue after residency, but I am keeping the possibility of a PGY2 open as I continue to develop my clinical interests. Outside of pharmacy, I enjoy playing tennis and pickleball, reading, baking, and playing video games. Most importantly, I enjoy spending time with my friends and family. Why Good Samaritan Hospital was the Right Fit for Me? The culture here at Good Samaritan is what initially drew me to the residency program during my APPE experience, as I was exploring other potential residency programs. The preceptors are genuinely passionate and excited about teaching, creating a fun learning environment. The medical residents and attendings frequently rely on the pharmacists, especially when on rounds. During my APPE experience, I was able to accelerate my growth in the profession of pharmacy in this environment. I found myself wanting to continue growing in this setting, which ultimately led me to rank the program highly. Residency Project: Anaerobic coverage with intravenous metronidazole 1000 mg daily versus metronidazole 500 mg every 8 hours in the setting of intra-abdominal infections. |
Previous Pharmacy Residents
| Past Residents | College of Pharmacy | Year | Initial Placement/ Current Position |
Residency Project |
|---|---|---|---|---|
| John “Jack” Hutchins, PharmD | Ohio Northern University | 2025-2026 | I/C: PGY2 Emergency Medicine University of Kentucky HealthCare | Retrospective Review of the Impact of R-EPOCH Administration Sequence on the Frequency of Rituximab Infusion Reactions in Diffuse Large B-Cell Lymphoma |
| Kaitlyn Champion, PharmD | University of Florida | 2024-2025 | I: PGY2 Pediatrics Prisma Health C: General Pediatric Medicine Clinical Pharmacy Specialist Prisma Health |
Retrospective Review of Supratherapeutic Gentamicin Levels in Neonates Following Maternal and Neonatal Gentamicin Infusion |
| Adam Klaserner, PharmD | University of Cincinnati | 2024-2025 | I: PGY2 Critical Care UCMC C: Critical Care Pharmacy Specialist at TriHealth Bethesda North |
Evaluation of clinical outcomes with varying doses of induction and paralytic agents in rapid sequence intubation |
| Vishal Prakash, PharmD | College of Pharmacy – Purdue University | 2023-2024 | I: PGY2 Ambulatory Care Northwestern Memorial Hospital C: Clinical Pharmacist Northwestern Memorial Hospital |
Asthma control in outpatients with mild asthma following the initiation of inhaler therapy |
| Jeff Mezzone, PharmD | University of Houston | 2022-2023 | I: PGY2 Internal Medicine – Good Samaritan TriHealth Hospital C: Clinical Pharmacy Specialist – Internal Medicine – University of Louisville Health |
Investigation of the benefit of oral ketamine dose escalation for pain modulation to the past residents list |
| Taylor Baumann, PharmD | Cedarville University | 2022-2023 | C: Clinical Pharmacy Specialist – Internal Medicine – University of Louisville Health | Retrospective review of deprescribing trends after initiation of SGLT2 inhibitors to account for known physiologic effects to the past residencts list |
| Megan Kosch, PharmD | University of Toledo | 2021-22 | I: PGY2 Internal Medicine - Good Samaritan TriHealth Hospital C: Ambulatory Care Specialist, Kettering Health |
Retrospective review of blood glucose control in inpatients receiving peritoneal dialysis |
| Alyson Rohrer, PharmD | Ohio Northern University | 2021-22 | I: PGY2 Internal Medicine - Good Samaritan TriHealth Hospital C: Clinical Pharmacy Specialist - Internal Medicine - University Hospitals Cleveland Medical Center |
Investigation of transitions of care issues related to the use of industry-supplied medication starter kits |
| Taha Alhayani, PharmD (PGY2) | Univ. of Cincinnati | 2021-22 | I/C: Clinical Pharmacy Specialist – Internal Medicine – Good Samaritan TriHealth Hospital | Efficacy of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in the Setting of Venous Thromboembolism or Stroke Prevention in Those with Morbid Obesity |
| Kenil Patel, PharmD (PGY2) | Univ. of Cincinnati | 2021-22 | I: Clinical Pharmacist – Good Samaritan TriHealth Hospital C: Clinical Informatics Pharmacist, TriHealth |
Validation of local risk factors for MDR community-acquired pneumonia |
| Allison Poston, PharmD | NEOMED | 2020-21 | I/C: Clinical Pharmacist – Southwest General Hospital | Retrospective review of IV iron supplementation in the setting of severe sepsis and septic shock |
| Shirin Bigdeliazari, PharmD, MBA | University of Kentucky | 2020-21 | I: Clinical Coordinator of Pharmacogenomics TriHealth C: Ambulatory Pharmacogenomics Clinical Specialist Ohio State University |
Implementation of a Pharmacogenomics Program |
| Stephanie Gurren, PharmD, BCPS | University of Kentucky | 2019-20 | I: PGY2 Internal Medicine – Good Samaritan TriHealth Hospital C: Clinical Pharmacy Specialist – Internal Medicine – Univ. of Cincinnati Medical Center |
Retrospective Review of Blood Pressure Response to Albumin vs Normal Saline for the Treatment of Intradialytic Hypotension |
| Joseph Schum, PharmD, BCPS | Univ. of Cincinnati | 2019-20 | I: PGY2 Internal Medicine – Good Samaritan TriHealth Hospital C: Clinical Pharmacy Specialist Ambulatory Care – Good Samaritan Faculty Medical Center |
Evaluation of procalcitonin clearance in patients with kidney dysfunction and its effects on antibiotic treatment duration |
| Mitchell Brinkworth, PharmD, BCPS | Purdue University | 2018-19 | I: PGY2 Internal Medicine – Good Samaritan TriHealth Hospital C: Internal Medicine Specialist, Adjunct Faculty University of Chicago/Roosevelt University |
PGY1 - Evaluation of a Piperacillin-Tazobactam Loading Dose Followed by Extended Infusions Protocol PGY2 - Appropriateness of Initiating Dual Antiplatelet Therapy Following an Ischemic Stroke or TIA in an Urban Teaching Hospital |
| Jenny C Lee, PharmD, BCPS | Northeastern University | 2018-19 | I: PGY2 Critical Care – Dartmouth Hitchcock Medical Center (Lebanon, NH) C: Critical Care Clinical Pharmacy Specialist - UC San Francisco Medical Center (San Francisco, CA) |
A Retrospective Review of Vancomycin Dosing in Neonates |
| Rachel Ruehl, PharmD, BCPS | Univ. of Cincinnati | 2017-18 | I: Health-System Pharmacy Specialist, ALK-Abello (Los Angeles, CA) C: Ambulatory Infectious Diseases Specialist – Mercy Health |
Implementation of a Pharmacist-managed Penicillin Skin Testing Service within a Community Teaching Hospital |
| Kelsey Schildknecht (Isfort), PharmD | Univ. of Cincinnati | 2017-18 | I: Clinical Pharmacist TriHealth Oncology Infusion Centers (Cincinnati, OH) C: TriHealth Specialty Pharmacy Clinical Manager |
A Comparison Between Pharmacist and Nurse Provision of Oral Chemotherapy Counseling and Follow-up: Impact on Patient Care and Adherence |
| Marissa Guillen, PharmD, BCCCP | University of Findlay | 2016-17 | I: Clinical Pharmacist – Good Samaritan TriHealth Hospital C: Emergency Medicine Specialist, Vanderbilt Medical Center |
Outcomes of an Inpatient Pharmacist-led Discharge Intervention on Medication-related Problems Post-discharge |
| Eric Place, PharmD, BCPS | The Ohio State University | 2016-17 | I: Clinical Pharmacist – The Ross Heart Hospital (Columbus, OH) C: Hematology/Oncology Specialist, OhioHealth Riverside Methodist Hospital |
Cost Analysis & Length of Stay Associated with Linezolid vs. Vancomycin Use in Methicillin-resistant Staphylococcus aureus Pneumonia in a Regional Health Organization |